Time-Restricted Feeding for Critical Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new feeding schedule for critically ill ICU patients. Researchers aim to determine if providing the same amount of nutrition over 12 hours (12-hour time-restricted feeding, or TRF12) is as effective as the usual 24-hour method. They examine how these schedules impact factors such as nutrient absorption and blood sugar levels. Adults in the ICU receiving continuous tube feedings may qualify for participation. As an unphased trial, this study presents a unique opportunity to contribute to innovative research that could enhance ICU care for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on feeding protocols for critically ill patients.
What prior data suggests that this time-restricted feeding protocol is safe for critically ill patients?
Research has shown that time-restricted feeding (TRF12) might be as safe as the usual 24-hour feeding schedule for critically ill patients. In TRF12, patients receive the same amount of nutrition over 12 hours instead of 24. Studies suggest that this method is generally well-tolerated. Patients on TRF12 did not experience more feeding-related issues than those on the 24-hour schedule. The goal is to provide necessary nutrition without causing additional health problems. Overall, both feeding schedules are expected to meet most patients' nutritional needs without added risks.12345
Why are researchers excited about this trial?
Researchers are excited about time-restricted feeding (TRF12) for critical illness because it offers a novel approach to nutrition delivery. Unlike the standard 24-hour continuous feeding (CONT24), which provides nutrition around the clock, TRF12 compresses the same nutritional intake into a 12-hour window by doubling the hourly feeding rate. This method could potentially improve metabolic outcomes and reduce complications associated with prolonged feeding periods. By aligning feeding times with the body's natural rhythms, TRF12 might enhance recovery and optimize energy utilization, promising a more efficient and potentially beneficial feeding strategy for critically ill patients.
What evidence suggests that this feeding protocol is effective for critically ill patients?
Research has shown that time-restricted feeding (TRF), which involves eating only during a set number of hours each day, can improve health. One study demonstrated that eating within a 10-hour window helped individuals with metabolic syndrome lose weight, lower blood pressure, and reduce unhealthy blood fats. Another study found that an 8-hour eating window led to significant weight loss in adults with obesity. Aligning feeding times with the body's natural rhythms might improve metabolism in critically ill patients. In this trial, participants will follow either a 12-hour TRF schedule or a continuous 24-hour feeding schedule. Current evidence indicates that both continuous and intermittent feeding schedules are equally safe for critically ill adults. These findings suggest that a 12-hour TRF schedule could be effective and safe for these patients.34567
Who Is on the Research Team?
Felicia Steger, PhD, MS, RD
Principal Investigator
University of Kansas Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 years old who are critically ill and in an intensive care unit (ICU), with orders to receive continuous enteral nutrition. It's not specified who can't join, but typically those with conditions affecting feeding tolerance or at risk of adverse effects from changes in nutrition might be excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 12-hour time-restricted feeding protocol or a 24-hour continuous feeding protocol
Follow-up
Participants are monitored for safety and effectiveness after treatment, including mental health and quality of life assessments
What Are the Treatments Tested in This Trial?
Interventions
- 12-hour time-restricted feeding (TRF12)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor